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Abstract
Objective. To determine the frequency of nine sexually 
transmitted pathogens, coinfections and risk factors in pa-
tients attending obstetrics and gynecology clinics in Jalisco, 
Mexico. Materials and methods. Samples from 662 
patients attending obstetrics and gynecology clinics were 
analyzed. Treponema pallidum, HIV, and HCV were detected 
by serology. HPV was detected by Polimerase Chain Reac-
tion (PCR), and its genotype was determined by Restriction 
Fragment Length Polymorphism (RFLP). Trichomonas vaginalis, 
HSV-1, HSV-2, Mycoplasma genitalium, Neisseria gonorrhoeae 
and T. pallidum were detected by multiplex PCR. Results. By 
serology, HIV frequency was 6.8%, T. pallidum was 2.26%, and 
HCV was 0.15%. By PCR, HPV frequency was 13.9%, (more 
frequent genotype was 16, 33.7%), followed by T. vaginalis 
(14.2%), HSV-1 (8.5%), M. genitalium (2,41%), N. gonorrhoeae 
(2.11%), HSV-2 (1.8%), and T. pallidum (1.05%). Patients 
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Resumen
Objetivo. Determinar la frecuencia de nueve patógenos 
de transmisión sexual, coinfecciones y factores de riesgo 
en pacientes que acudieron a una consulta de ginecología 
y obstetricia en Jalisco, México. Material y métodos. 
Se analizaron muestras de 662 pacientes que asistieron a la 
consulta de ginecología y obstetricia. Se detectaron Treponema 
pallidum, VIH y VHC mediante serología. Se detectó VPH por 
Reacción de Cadena de Polimerasa (PCR) y sus genotipos se 
detectaron por Polimorfismos de Longitud de Fragmentos 
de Restricción (RFLP). Se detectaron Trichomonas vaginalis, 
VHS-1, VHS-2, Mycoplasma genitalium, Neisseria gonorrhoeae y 
T. pallidum por PCR múltiple. Resultados. Por serología, la 
frecuencia de VIH fue 6.8%, de T. pallidum fue 2.26% y de VHC 
fue 0.15%. Por PCR, la frecuencia más alta fue de VPH (13.9%, el 
genotipo más frecuente fue el 16, 33.7%), seguida de T. vaginalis 
(14.2%), VHS-1 (8.5%), M. genitalium (2.41%), N. gonorrhoeae 
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infected with T. vaginalis were more likely to have multiple 
coinfections (p = 0.01). Conclusion. The frequency of HPV, 
HVS-1, HSV-2, M. genitalium and T. vaginalis was lower than 
that reported. However, a high frequency of HIV, T. pallidum, 
and N. gonorrhoeae was detected.
Keywords: sexually transmitted disease; co-infections; preg-
nancy; gynecology; Mexico
(2.11%), VHS-2 (1.8%) y T. pallidum (1.05%). Los pacientes 
infectados con T. vaginalis presentaron más probabilidades de 
tener múltiples coinfecciones (p = 0.01). Conclusiones. La 
frecuencia de infección por VPH, VHS-1, VHS-2, M. genitalium y 
T. vaginalis fue menor a lo reportado. Sin embargo, se detectó 
una alta frecuencia de VIH, T. pallidum, y N. gonorrhoeae. 
Palabras clave: infecciones de transmisión sexual; coinfección; 
embarazo; ginecología; México
Sexually transmitted infections (STIs) are caused by more than 30 pathogens.1 Each year, an estimated 
of 500 million individuals are infected with one of the 
four curable STIs. Some of these infections can have seri-
ous consequences beyond the immediate effects of the 
disease itself, such as a transmission of infection from 
mother to child during pregnancy or childbirth, and 
chronic illness. Furthermore, other STIs cause significant 
health problems to the population.2
 In Mexico, STIs are one of the top five diseases on 
demand for medical care and are among the top ten 
causes of general morbidity in the group of 15-44 years 
old individuals, with an average of 220 000 cases annu-
ally.3
 Although there are some STI studies in Mexico,4,5 
the frequency of STIs is not well known. There are few 
studies on the detection of these microorganisms by 
PCR, correlated coinfections, and risk factors involved.
 The aim of this study was to determine the fre-
quency of nine sexually transmitted pathogens, coinfec-
tions and risk factors in patients attending obstetrics and 
gynecology clinics in Jalisco, Mexico.
Materials and methods
Ethics statement
This study was revised and approved by the Ethics Com-
mittee of Hospital Civil de Guadalajara “Fray Antonio 
Alcalde” (Approval no. 062/13). Written informed con-
sent was obtained from patients or from caretakers, or 
guardians on behalf of the minors enrolled in this study.
Study population
Six hundred and sixty-two patients attending for the 
first time the obstetrics and gynecology clinics at the 
Hospital Civil de Guadalajara “Fray Antonio Alcalde”, 
from September 2013 to August 2014 were enrolled in 
this study. Sociodemographic, behavioral and biological 
data associated with genital infections were collected.
Sample collection, microbiological culture, 
and DNA extraction
For each patient, two endocervical cotton swabs trans-
ported in Stuart´s medium, and serum samples were 
collected.
 One cotton swab was used for microbiological 
culture and the second was used for DNA extraction. 
The culture was performed for identification of bacteria 
and yeast as recommended by the American Society for 
Microbiology.6
 For DNA extraction, a cotton swab was resuspend-
ed in 200 μL of 100 mM Tris-HCl. Following vortexing, 
150 μg of lysozyme was added, and the mixture was in-
cubated at 37°C overnight, and then, genomic DNA was 
extracted with a standard phenol-chloroform-isoamyl 
alcohol protocol.
Serological assays
IgG, IgM anti-T. pallidum antibodies, HIV antibodies 
and p24 antigen were detected in serum samples by 
chemoluminescence using the ARCHITECT instru-
ment (Abbott, Germany) according to manufacturer’s 
instructions.7 Qualitative detection of HCV antibodies 
in serum samples was performed using gold colloid 
immunochromatography with the Advanced Quality 
Rapid Anti-HCV Test, Acitrack (Mexico City), according 
to manufacturer’s instructions.
VPH detection and genotyping
HPV detection was performed by PCR amplifying a 
highly conserved region of the L1 gene as previously 
described.8 Positive samples were genotyped by RFLP 
as described.9
Multiplex PCR for detection of pathogens 
Detection of T. vaginalis, HSV-1, HSV-2, M. genitalium, 
N. gonorrhoeae, and T. pallidum was performed using 
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a multiplex PCR.10 The final volume (25 uL) of PCR 
reaction consisted of 2.5 uL of 10X PCR-buffer, 100 ng 
of DNA, 3 mM MgCl2, 200 uM of each dNTP, and 1 U 
of Taq polymerase (Bioline, London, UK). 
Statistical analysis
The qualitative variables are summarized by calculating 
absolute frequency expressed in percentages. Two by 
two tables were used to assess the possible association 
between a risk factor “exposure” and a result “infec-
tion”. Multivariate logistic regression models were used 
to estimate the odds ratio (OR) and 95% confidence 
intervals (95% CI) for the association between risk fac-
tors and prevalence of STIs. 
 The variables studied regarding the risk factors 
were divided into three groups: sociodemographic 
data (age, occupation [housewife, employee, merchant, 
professional, student], marital status [single, divorced, 
widow, separated, married, living with a partner]); 
behavioral data (alcohol consumption, smoking, age 
of first sexual activity [< 18 years, ≥ 18 years], number 
of sexual partners [1, 2-4, ≥ 5], contraceptive methods 
[hormonal, condom, intrauterine device, bilateral tubal 
occlusion, none]); and biological factors (pregnant dur-
ing the sampling, previous pregnancies, complications 
of previous pregnancy infections, bleeding, the risk of 
spontaneous abortion, premature birth, ectopic preg-
nancy, previous abortions, pelvic inflammatory disease).
Results 
Study population
From 30 000 female patients estimated to visit the 
obstetrics and gynecology department, 662 patients 
were enrolled in this study. Only patients who agreed 
to participate and were attending the clinic for the first 
time in the study period were included. The mean age 
of the study population was 31 years (14 to 78 years). 
The largest proportion of patients was aged 20–29 years 
(38.5%, n= 255). The majority of patients were house-
wives 69.5% (n= 460). At the time of sampling, 43.3% 
(n= 287) of patients were pregnant; most of the patients 
(93.8% n= 621) had been pregnant at some point in their 
lives either before or during the sampling.
Microbiological culture 
In 53% (n= 336) of patients there was no normal mi-
crobiota. Twenty-eight species non-associated to an 
STI were detected in the microbiological culture: En-
terococcus faecalis (33.9%, n= 225); followed by Candida 
albicans (23.4%, n= 155) and Escherichia coli (19%, n= 
126); Acinetobacter baumannii, Citrobacter freundii, Citro-
bacter diversus, Elizabethkingia meningoseptica, Enterobacter 
aerogenes, Flavimonas oryzihabitans, Klebsiella oxytoca, 
Morganella morganii, Providencia rettgeri, Staphylococcus 
saprophyticus and Streptococcus pyogenes (1% each). N. 
gonorrhoeae not detected.
Detection of pathogens by PCR
and by serology
From the study population, 47.7% had, at least, one 
microorganism associated with an STI; 2.26% (n= 
15) had IgG/IgM antibodies against T. pallidum (7 of 
them were pregnant) and 1.05% (n= 7) was positive by 
the multiplex-PCR for T. pallidum (two of them were 
pregnant). N. gonorrhoeae was detected in 2.11% (n= 
14) patients by the multiplex PCR (none was positive 
for culture).
 HPV was detected in 13.9% (n= 92) of patients. Ac-
cording to the results of genotyping by RFLP, the HPV 
genotype 16 was the most frequently detected (33.7%, n= 
31), followed by genotype 31 (15.2%, n= 14), 45 (14.1%, 
n= 13), 66 (12%, n= 11) and 58 (10.9%, n= 10). Genotypes 
detected are shown in table I.
 HIV was detected in 6.8% (n= 45) of the patients by 
ELISA, and all were confirmed by Western-blot. Only 
one patient (0.15%) was positive for HCV.
Table I
Frequency oF HPV genotyPe detected
in tHe studied PoPulation
Risk Genotype N %
High 16 31 33.7
18, 51, 73 1 1.1
31 14 15.2
33 9 9.8
35, 39, 53, 82 2 2.2
45 13 14.1
52 8 8.7
58 10 10.9
59 6 6.5
66 11 12.0
Low 6 28 30.4
11, 43, 61, 81 2 2.2
13 7 7.6
30, 42, 54, 72, 74, 
84, 91 1 1.1
40, 69 3 3.3
62, 64 16 17.4
70 7 7.6
Indeterminate 26 1 1.1
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 Of the population studied, 8.5% (n= 56) was posi-
tive for HSV-1 by amplifying the glycoprotein G (US4) 
gene; and 1.8% (n= 12) was positive for HSV-2 by am-
plifying the glycoprotein D (US6) gene. Furthermore, 
14.2 % (n= 94) were positive for T. vaginalis by PCR. M. 
genitalium was detected in 2.41% (n= 14) of the study 
population.
Association of sexually transmitted 
pathogens with sociodemographic, 
behavioral, and biological factors
and coinfections
Patients in the age range of 14-19 years were less fre-
quently HIV-infected and, in contrast, patients in the 
age range 20-29 years or divorced/widowed/separated 
were more likely to be HIV-infected.
 Patients with ≥5 sexual partners were more likely 
to be HIV-infected. The same observation was detected 
for HPV-infected patients (table II).
 The infection of HSV-2 correlated with bilateral 
tubal occlusion as a contraceptive method (p= 0.005) 
and the presence of pelvic inflammatory disease as a 
complication of previous pregnancies (p=0.032). 
 Sixteen coinfections were detected as statistically 
significant: HIV-infected patients were more likely to be 
coinfected with HPV (p = 0.01) and patients infected with 
HSV-1 were more likely to be coinfected with T. pallidum 
(p = 0.02), M. genitalium, T. vaginalis and N. gonorrhoeae 
(p = 0.01 for all); unlike patients infected with HSV-2, 
which were more likely to be coinfected only with M. 
genitalium (p = 0.01).
 Finally, patients infected with T. vaginalis were more 
likely to have multiple coinfections: HPV (p = 0.01), HIV 
(p = 0.02), T. pallidum (p = 0.01), M. genitalium (p = 0.02) 
and HSV-1 (p = 0.01) (table II).
Discussion
Most studies regarding STIs in Mexico have been limited 
to the assessment of individual pathogens and popula-
tions with clinical symptoms of the disease or high-risk 
behaviors with limited methodologies.5,11-13 This study 
was performed in women attending gynecology and 
obstetrics clinics for routine testing and involves nine 
pathogens detected by molecular, serological and micro-
biological methods. Thus, contributing to increase the 
information available about STIs in Mexico.
 The overall frequency of STI observed in the study 
population was 47.4%, which is similar to the frequency 
found in a study in Korea. The study included 799 
healthy women. In the Korean study, 49.2% of the 
population had one or more STI.14 However, compared 
to other studies, the frequency reported in our study 
was higher than previously reported; for example, in an 
earlier study of a Paraguayan population that included 
181 sexually active women, the frequency of STI was 
41.4%.15 Furthermore, a study of 734 Brazilian women 
detected a frequency of 19.6%.16 A report that included 
201 Mexican women showed a frequency of 57.7% of 
STI;17 this data is superior to ours.
 In Mexico, studies regarding the detection of T. 
pallidum have focused primarily on risk groups of in-
fection. The study by Conde-González et al. detected a 
prevalence of T. pallidum antibodies of 2.66% in women, 
which is similar to our result (2.26%).18 The study of 
Conde-González et al. was performed in the general 
population. The differences in populations studied may 
explain the discrepancies in results.
 Early detection of syphilis during pregnancy is es-
sential for the health of the mother and fetus, allowing 
the prompt instauration of treatment. In our study, 2.4% 
(n=7) pregnant patients had IgG/IgM antibodies, and 
0.7% (n=2) was positive by PCR. In 2014, the prevalence 
of syphilis in pregnant women in Mexico was 0.38%. 
This percentage was obtained by serology.19 The fre-
quency observed in pregnant patients in our population 
is higher than previously reported in Mexico. 
 Of the seven (1%) patients positive by for T. palli-
dum by PCR, three were also positive by serology; this 
difference could be a result of the window period of 
infection, which lasts approximately three weeks. All 
positive patients were given medical treatment and 
close monitoring. No cases of congenital syphilis were 
detected.
 The WHO estimates a prevalence of 0.8% of gonor-
rhea among women in America;20 comparing our data 
with these reports, the frequency of 2.11% detected in 
our patients is high. However, it is necessary to take into 
account that the estimation of the WHO may be based 
on culture techniques, which are less sensitive than the 
sensitivity reported for PCR (sensitivity and specificity 
reported by 100%).21 In fact, we did not detect N. gonor-
rhoeae by culture.
 The frequency of HIV reported in our population 
was 6.8%; this rate is very high compared with frequency 
reported in world population and our region. The WHO 
estimated an overall prevalence of 0.8% in 2013 in the 
adult population in Latin America and this data seems 
to indicate a stabilization of the epidemic.22
 HIV-positive patients were aware of their infected 
status and attended to receive supporting and medical 
care; this may be a bias in our study. We hypothesize 
that this fact may explain the higher frequency ob-
served for Treponema pallidum and gonorrhoeae than 
in previous reports.
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Table II
associations oF sexually transmitted PatHogens witH sociodemograPHic, beHaVioral,
and biological cHaracteristics oF tHe study PoPulation and coinFections
Total positive population T. pallidum positive by serology HIV positive by serology HPV positive
Characteristics
[n (%),
n= 662]
[n (%), 
n= 15]
P
Adjusted OR
(95% CI)
[n (%),
n= 45]
P
Adjusted OR
(95% CI)
[n (%),
n= 92]
P
Adjusted OR
(95% CI)
Sociodemographic data
      Age group (years)
14 – 19 93 (14.05) 2 (13.33) 0.93 0.94 (0.20, 4.23) 0 (0) 12 (13.04) 0.76 0.91 (0.47, 1.73)
20 – 29 255 (38.52) 5 (33.33) 0.67 0.79 (0.26, 2.35) 6 (13.33) 0 0.22 (0.09, 0.54) 32 (34.78) 0.42 0.83 (0.52, 1.31)
30 – 39 186 (28.10) 4 (26.67) 0.9 0.92 (0.29, 2.95) 23 (51.11) 0 2.91 (1.58, 5.36) 32 (34.78) 0.12 1.44 (0.90, 2.29)
≥ 40 129 (19.49) 4 (26.67) 0.46 1.53 (0.48, 4.89) 16 (35.56) 0 2.48 (1.30, 4.73) 16 (17.39) 0.61 0.86 (0.48, 1.53)
Occupation
Housewife 460 (69.49) 9 (60.00) 0.41 0.64 (0.22, 1.84) 30 (66.67 0.65 0.86 (0.45, 1.64) 66 (71.74) 0.63 1.13 (0.69, 1.83)
Employee/merchant 106 (16.01) 4 (26.67) 0.24 1.96 (0.61, 6.29) 14 (31.11) 0 2.61 (1.33, 5.09) 17 (18.48) 0.45 1.24 (0.70, 2.20)
Professional 63 (9.52) 1 (6.67) 0.7 0.67 (0.08, 5.21) 0 (0) 0.02 5 (5.43) 0.15 0.51 (0.19, 1.30)
Student 33 (4.98) 1 (6.67) 7.62 1.37 (0.17, 10.76) 1 (2.22) 0.37 0.41 (0.05, 3.11) 4 (4.35) 0.76 0.85 (0.29, 2.47)
Marital status
Single 140 (21.15) 0 (0) 0.24 17 (37.78) 0.01 2.43 (1.29, 4.59) 25 (27.17) 0.12 1.47 (0.89, 2.44)
Divorced/widowed/separated 22 (3.32) 5 (33.33) 0.46 7 (15.56) 0 7.39 (2.84, 19.21) 4 (4.35) 0.55 1.39 (0.46, 4.21)
Married 238 (35.95) 5 (33.33) 0.83 0.88 (0.30, 2.63) 7 (15.56) 0 0.30 (0.13, 0.70) 27 (29.35) 0.15 0.71 (0.43, 1.14)
Living with partner 262 (39.58) 5 (33.33) 0.61 0.75 (0.25, 2.24) 14 (31.11) 0.22 0.67 (0.35, 1.28) 36 (39.13) 0.92 0.98 (0.62, 1.53)
Behavioral data
      Age at first intercourse (years)
< 16 years 140 (21.15) 3 (20) 0.91 0.93 (0.25, 3.34) 14 (31.11) 0.09 1.76 (0.90, 3.40) 25 (27.17) 0.12 1.47 (0.89, 2.44)
≥ 16 years 522 (78.85) 12 (80) 0.91 1.07 (0.29, 3.86) 31 (68.89) 0.09 0.65 (0.29, 1.10) 67 (72.83) 0.12 0.68 (0.04, 1.12)
No. of previous sex partners
0-1 318 (48.04) 9 (60) 0.34 1.64 (0.57, 4.66) 11 (24.44) 0.001 0.32 (0.16, 0.65) 36 (39.13) 0.06 0.66 (0.41, 102)
2 – 4 279 (42.15) 6 (40) 0.86 0.91 (0.32, 2.59) 23 (51.11) 0.2 1.47 (0.80, 2.70) 40 (43.48) 0.76 1.07 (0.68, 1.66)
≥ 5 65 (9.82) 0 (0) 0.19 11 (24.44) 0.001 3.37 (1.61, 7.03) 16 (17.39) 0.009 2.23 (1.21, 4.13)
Contraceptive methods
Hormonal 102 (15.41) 0 (0) 0.09 4 (8.89) 0.21 0.51 (0.18, 1.47) 13 (14.13) 0.71 0.89 (0.47,1.66)
Condom 249 (37.61) 7 (46.67) 0.46 1.46 (0.52, 4.08) 4 (8.89) 0.32 1.35 (0.73, 2.49) 39 (42.39) 0.3 1.26 (0.80, 1.97)
IUD 67 (10.12) 1 (6.67) 0.65 0.629 (0.08, 4.85) 20 (44.44) 0.77 0.85 (0.29, 2.47) 13 (14.13) 0.16 1.57 (0.82, 3.01)
Bilateral tubal occlusion 40 (6.04) 0 (0) 0.32 4 (8.89) 0.4 1.57 (0.53, 4.63) 4 (4.35) 0.46 0.67 (0.23, 1.94)
None 204 (30.82) 7(46.67) 0.17 1.99 (0.71, 5.58) 13 (28.89) 0.77 0.90 (0.46, 1.76) 23 (25) 0.19 0.72 (0.43, 1.18)
      Alcohol use 145 (21.90) 1 (6.67) 0.14 0.25 (0.03, 1.91) 11 (24.44) 0.66 1.16 (0.57, 2.36) 23 (25) 0.43 1.24 (0.73, 2.04)
      Current smoker 200 (30.21) 3 (20.00) 0.38 0.57 (0.15, 2.04) 14 (0.02) 0.89 1.04 (0.54, 2.01) 33 (1.62) 0.2
Biological factors
      Pregnant at sampling 287 (43.35) 7 (46.67) 0.79 1.14 (0.41, 3.20) 1 (2.22) 0 0.02 (0.004, 0.19) 39 (42.39) 0.84 0.96 (0.61, 1.49)
      Previous pregnancies 621 (93.81) 13 (86.67) 0.26 0.42 (0.09, 1.96) 44 (97.78) 0.24 3.13 (0.42, 23.31) 88 (95.65) 0.39 1.57 (0.54, 4.51)
Complications of previous pregnancy
Infections 386 (58.31) 7 (46.67) 0.35 0.61 (0.22, 1.72) 19 (42.22) 0.02 0.49 (0.27, 0.91) 5 (5.43) 0.7 0.92 (0.58, 1.43)
Bleeding 69 (10.42) 0 (0) 0.18 4 (8.89) 0.72 0.82 (0.28, 2.38) 5 (5.43) 0.09 0.45 (0.17, 1.61)
Risk of spontaneous abortion 116 (17.52) 1 (6.67) 0.99 8 (17.78) 0.96 1.01 (0.42. 2.23) 22 (23.91) 0.08 1.59 (0.93, 2.69)
Premature birth 50 (7.55) 0 (0) 0.26 0.33 (0.04, 2.53) 1 (2.22) 0.16 0.26 (0.03, 1.95) 9 (9.78) 0.383 1.39 (0.65, 2.98)
Ectopic pregnancy 9 (1.36) 0 (0) 0.64 0 (0) 0.41 0 (0) 0.22
Previous abortions 163 (24.62) 3 (20) 0.99 12 (26.67) 0.02 25 (27.17) 0.35
Pelvic inflammatory disease 295 (44.56) 1 (6.67) 0.86 1.09 (0.39, 3.03) 21 (46.67) 0.76 1.09 (0.59, 2.00) 41 (44.57) 0.99 1 (0.64, 1.55)
Coinfections
HPV (PCR) 92 (13.90) 3 (20) 0.48 11 (24.44) 0.034 2.14 (1.04, 4.39)
HIV (Serology) 45 (6.80) 1 (6.67) 0.98 0.97 (0.12, 7.61) 11 (11.96) 4.48 2.14 (1.04, 4.39)
T. pallidum (Serology) 15 (2.27) 0.01 1 (2.22) 0.98 0.97 (0.12, 7.61) 3 (3.26) 0.48 1.56 (0.43, 5.66)
T. pallidum (PCR) 7 (1.06) 3 (20) 0 40 (8.09, 199.48) 1 (2.22) 0.42 2.31 (0.27, 19.65) 3 (3.26) 0.02 4.77 (1.05, 21.66)
HSV-2 (PCR) 12 (1.81) 1 (6.67) 0.15 4.13 (0.49, 34.21) 0 (0) 0.345 2 (2.17) 0.78 1.24 (0.26, 5.77)
M. genitalium (PCR) 16 (2.42) 0 (0) 0.53 2 (4.44) 0.35 2 (0.44, 9.10) 1 (1.09) 0.37 0.41 (0.05, 3.11)
T. vaginalis (PCR) 94 (14.20) 4 (26.67) 0.162 2.25 (0.70, 7.22) 3 (6.67) 0.13 0.41 (0.12, 1.36) 25 (27.17) 0 2.7 (1.60, 4.57)
N. gonorrhoeae (PCR) 14 (2.11) 0 (0) 0.56 2 (4.44) 0.26 2.34 (0.50, 10.81) 2 (2.17) 0.96 1.03 (0.22, 4.69)
HSV-1(PCR) 56 (8.46) 1 (6.67) 0.8 0.76 (0.99, 5.95) 2 (4.44) 0.31 0.48 (0.11, 2.05) 10 (10.87) 0.37 1.38 (0.67, 2.86)
(continues…)
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Total positive population T. vaginalis positive by PCR HVS-1 positive by PCR HVS-2 positive by PCR
Characteristics 
[n (%),
n= 662]
[n (%),
n= 94]
P
Adjusted OR 
(95% CI)
[n (%),
n= 56]
P
Adjusted OR
(95% CI)
[n (%),
n= 12]
P
Adjusted OR
(95% CI)
Sociodemographic data
      Age group (years)
14 – 19 93 (14.05) 14 (14.89) 0.79 1.08 (0.58, 2.00) 9 (16.07) 0.64 1.19 (0.56, 2.51) 0 (0) 0.15
20 – 29 255 (38.52) 40 (42.55) 0.38 1.21 (0.78, 1.89) 22 (39.29) 0.9 1.03 (0.59, 1.81) 3 (25) 0.33 0.52 (0.14, 1.96)
30 – 39 186 (28.10) 25 (26.60) 0.72 0.91 (0.56, 1.49) 17 (30.36) 0.69 1.12 (0.62, 2.04) 5 (41.67) 0.29 1.85 (0.58, 5.90)
≥ 40 129 (19.49) 15 (15.96) 0.8 0.76 (0.42, 1.37) 8 (14.29) 0.31 0.67 (0.31, 1.46) 4 (33.33) 0.21 2.12 (0.62, 7.15)
Occupation
Housewife 460 (69.49) 65 (69.15) 0.91 0.97 (0.60, 1.56) 43 (76.79) 0.22 1.48 (0.78, 2.83) 8 (66.67) 0.82 0.87 (0.25, 2.92)
Employee/merchant 106 (16.01) 18 (19.15) 0.34 1.3 (0.74, 2.29) 4 (7.14) 0.06 0.38 (0.13, 1.08) 4 (33.33) 0.09 2.71 (0.80, 9.19)
Professional 63 (9.52) 6(6.38) 0.26 0.61 (0.25, 1.46) 5 (8.93) 0.87 0.92 (0.35, 2.41) 0 (0) 0.25
Student 33 (4.98) 5 (5.32) 0.87 1.08 (0.40, 2.88) 4 (7.14) 0.43 1.53 (0.51, 4.52) 0 (0) 0.42
Marital status
Single 140 (21.15) 18 (19.15) 0.6 0.86 (0.49, 1.50) 9 (16.07) 0.33 0.69 (0.33, 1.45) 2 (16.67) 0.7 0.74 (0.16, 3.42)
Divorced/widowed/separated 22 (3.32) 2 (2.13) 0.48 0.59 (0.13, 2.59) 2 (3.57) 0.91 1.08 (0.24, 4.76) 1 (8.33) 0.32 2.72 (0.33, 22.07)
Married 238 (35.95) 30 (31.91) 3.79 0.811 (0.50, 1.29) 22 (39.29) 0.58 1.16 (0.66, 2.04) 7 (58.33) 0.1 2.53 (0.79, 8.09)
Living with partner 262 (39.58) 44 (46.81) 0.12 1.41 (0.91, 2.19) 23 (41.07) 0.81 1.07 (0.61, 1.86) 2 (16.67) 0.1 0.3 (0.07, 1.38)
Behavioral data
      Age at first intercourse (years)
< 16 years 140 (21.15) 17 (18.09) 0.43 0.79 (0.45, 1.40) 11 (19.64) 0.77 0.90 (0.45, 1.79) 2 (16.67) 0.7 0.74 (0.16, 3.42)
≥ 16 years 522 (78.85) 77 (81.91) 0.43 1.25 (0.71, 2.19) 45 (80.36) 0.77 1.10 (0.556 2.220) 10 (83.33) 0.7 1.34 (0.29, 6.22)
No. of previous sex partners
0-1 318 (48.04) 43 (45.74) 0.63 0.89 (0.58, 1.39) 30 (53.57) 0.38 1.27 (0.73, 2.20) 5 (41.67) 0.65 0.76 (0.242, 2.44)
2 – 4 279 (42.15) 41 (43.62) 0.755 1.07 (0.69, 1.66) 20 (35.71) 0.3 0.74 (0.42, 1.31) 6 (50) 0.57 1.38 (0.44, 4.32)
≥ 5 65 (9.82) 10 (10.64) 0.73 1.1 (0.54, 2.26) 6 (10.71) 0.81 1.11 (0.45, 2.70) 1 (8.33) 0.86 0.83 (0.10, 6.55)
Contraceptive methods  
Hormonal 102 (15.41) 20 (21.28) 0.08 1.6 (0.92, 2.76) 9 (16.07) 0.88 1.05 (0.50, 2.22) 3 (25) 0.35 1.85 (0.49, 6.97)
Condom 249 (37.61) 33 (35.11) 0.58 0.88 (0.55, 1.39) 25 (44.64) 0.25 1.37 (0.79, 2.38) 5 (41.67) 0.77 1.18 (0.37, 3.78)
IUD 67 (10.12) 13 (13.83) 0.19 1.52 (0.79, 2.92) 6 (10.71) 0.87 1.07 (0.44, 2.60) 0 (0) 0.24
Bilateral tubal occlusion 40 (6.04) 4 (4.26) 0.43 0.65 (0.22, 1.89) 2 (3.57) 0.41 0.55 (0.13, 2.35) 3 (25) 0.005 5.52 (1.43, 21.26)
None 204 (30.82) 24 (25.53) 0.23 0.73 (0.45, 1.21) 14 (25) 0.32 0.73 (0.38, 1.36) 1 (8.33) 0.08 0.2 (0.02, 1.56)
      Alcohol use 145 (21.90) 25 (26.60) 0.235 1.35 (0.820, 2,23 9 (16.07) 0.27 0.66 (0.31, 1.38) 1 (8.33) 0.25 0.31 (0.04, 2.49)
      Current smoker 200 (30.21) 27 (28.72) 0.73 0.92 (0.56, 1.48) 11 (19.64) 0.07 0.53 (0.27, 1.06) 4 (33.33) 0.81 1.15 (0.34, 3.89)
Biological factors
      Pregnant at sampling 287 (43.35) 51 (54.26) 0.02 1.66 (1.07, 2.58) 28 (50) 0.29 1.34 (0.77, 2.31) 3 (25) 0.19 0.43 (0.11, 1.60)
      Previous pregnancies 621 (93.81) 87 (92.55) 0.63 0.81 (0.35, 1.89) 52 (92.86) 0.79 0.87 (0.29, 2.53) 12 (100) 0.36
Complications of previous pregnancy 
Infections 386 (58.31) 54 (57.45) 0.85 0.96 (0.61, 1.49) 33 (58.93) 0.92 1.02 (0.59, 1.74) 6 (50) 0.55 0.71 (0.22, 2.22)
Bleeding 69 (10.42) 5 (5.32) 0.08 0.44 (0.17, 1.13) 6 (10.71) 0.94 1.03 (0.42, 2.50) 0 (0) 0.23
Risk of spontaneous abortion 116 (17.52) 14 (14.89) 0.46 0.8 (0.43, 1.46) 7 (12.50) 0.3 0.65 (0.28, 1.47) 3 (25) 0.49 1.58 (0.42, 5.94)
Premature birth 50 (7.55) 7 (7.45) 0.96 0.982 (0.428, 2.25) 8 (14.29) 0.04 2.23 (.01, 5.03) 1 (8.33) 0.91 1.11 (0.14, 8.81)
Ectopic pregnancy 9 (1.36) 2 (2.13) 0.48 1.74 (0.35, 8.51) 2 (3.57) 0.13 3.16 (0.64, 15.63) 0 (0) 0.68
Previous abortions 163 (24.62) 18 (19.15) 0.66 11 (19.64) 0.78 5 (41.67) 0.86
Pelvic inflammatory disease 295 (44.56) 44 (46.81) 0.63 1.11 (0.71, 1.72) 28 (50) 0.39 1.27 (0.73, 2.19) 9 (75) 0.032 3.81 (1.02, 14.23)
Coinfections
HPV (PCR) 92 (13.90) 25 (26.60) 0 2.7 (1.60, 4.57) 10 (17.86) 0.37 (0.67, 2.86) 2 (16.7) 0.78 1.24 (0.26, 5.77)
HIV (Serology) 45 (6.80) 3 (3.19) 0.13 0.41 (0.12, 1.36) 2 (3.57) 0.31 0.48 (0.11, 2.05) 0 (0) 0.34
T. pallidum (Serology) 15 (2.27) 4 (4.26) 0.16 2.25 (0.70, 7.22) 1 (1.79) 0.8 0.76 (0.09, 5.95) 1 (8.3) 0.15 4.13 (0.49, 34.21)
T. pallidum (PCR) 7 (1.06) 4 (4.26) 0 8.37 (1.84, 38.01) 2 (3.57) 0.05 4.45 (0.84, 23.49) 0 (0) 0.71
HSV-2 (PCR) 12 (1.81) 2 (2.13) 0.8 1.21 (0.26, 5.62) 1 (1.79) 0.98 0.98 (0.12, 7.76)
M. genitalium (PCR) 16 (2.42) 5 (5.32) 0.04 2.84 (0.96, 8.38) 4 (7.14) 0.01 3.8 (1.18, 12.22) 2 (16.7) 0.001 9.08 (1.82, 45.35)
T. vaginalis (PCR) 94 (14.20) 35 (62.50) 0 15.42 (8.44, 28.26) 2 (16.7) 0.8 1.21 (0.26, 5.62)
N. gonorrhoeae (PCR) 14 (2.11) 0 (0) 0.12 4 (7.14) 0.006 4.58 (1.39, 15.12) 1 (8.3) 0.13 4.45 (0.53, 37.09)
HSV-1(PCR) 56 (8.46) 35 (37.23) 0 15.45 (8.44, 28.26) 1 (8.3) 0.98 0.98 (0.12, 7.76)
(continuation)
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Total positive population M. genitalium positive by PCR N. gonorrhoeae positive by PCR T. pallidum positive by PCR
Characteristics 
[n (%),
n= 662]
[n (%),
n= 16]
P
Adjusted OR
 (95% CI)
[n (%),
n= 14]
P
Adjusted OR
(95% CI)
[n (%),
n= 7]
P
Adjusted OR
(95% CI)
Sociodemographic data
      Age group (years)
14 – 19 93 (14.05) 0 (0) 0.1 1 (7.14) 0.45 0.46 (0.06, 3.59) 0 (0) 0.28
20 – 29 255 (38.52) 7 (43.75) 0.66 1.24 (0.45, 3.39) 6 (42.86) 0.73 1.2 (0.41, 3.50) 2 (28.57) 0.58 0.63 (0.12, 3.30)
30 – 39 186 (28.10) 4 (25) 0.78 0.85 (0.271, 2.66) 1 (7.14) 0.07 0.19 (0.02, 1.48) 3 (42.86) 0.38 1.93 (0.42, 8.72)
≥ 40 129 (19.49) 5 (31.25) 0.22 1.93 (0.65, 5.66) 6 (42.86) 0.02 3.23 (1.10, 9.49) 2 (28.57) 0.53 1.67 (0.32, 8.75)
Occupation
Housewife 460 (69.49) 14 (87.50) 0.11 3.11 (0.70, 13.84) 11 (78.57) 0.46 1.61 (0.44, 5.84) 3 (42.86) 0.12 0.32 (0.07, 1.45)
Employee/merchant 106 (16.01) 2 (12.50) 0.7 0.75 (0.16, 3.36) 2 (14.29) 0.87 0.88 (0.19, 3.99) 3 (42.86) 0.04 4.06 (0.89, 18.43)
Professional 63 (9.52) 0 (0) 0.18 1 (7.14) 0.76 0.72 (0.09, 5.65) 1 (14.29) 0.66 1.59 (0.18, 13.45)
Student 33 (4.98) 0 (0) 0.35 0 (0) 0.38 0 (0) 0.54
Marital status
Single 140 (21.15) 1 (6.25) 0.14 0.24 (0.03, 1.85) 5 (35.71) 0.17 2.11 (0.69, 6.40) 3 (42.86) 0.15 2.83 (0.62, 12.82)
Divorced/widowed/separated 22 (3.32) 0 (0) 0.45 0 (0) 0.48 0 (0) 0.62
Married 238 (35.95) 6 (37.50) 0.89 1.07 (0.38, 2.98) 4 (28.57) 0.56 0.70 (0.22, 2.28) 4 (57.14) 0.24 2.39 (0.53, 10.81)
Living with partner 262 (39.58) 9 (56.25) 0.16 1.99 (0.73, 5.43) 5 (35.71) 0.76 0.84 (0.28, 2.55) 0 (0) 0.03
Behavioral data
      Age at first intercourse (years)
< 16 years 140 (21.15) 4 (25) 0.7 1.25 (0.39, 3.93) 5 (35.71) 0.17 2.11 (0.696, 6.40) 1 (14.29) 0.65 0.619 (0.074, 5.18)
≥ 16 years 522 (78.85) 12 (75) 0.7 0.8 (0.254, 2.52) 9 (64.29) 0.17 0.47 (0.15, 1.43) 6 (85.71) 0.65 1.61 (0.19, 13.53)
No. of previous sex partners
0-1 318 (48.04) 6 (37.50) 0.39 0.64 (0.23, 1.78) 5 (35.71) 0.35 0.59 (0.19, 1.79) 3 (42.86) 0.78 0.81 (0.18, 3.64)
2 – 4 279 (42.15) 6 (37.50) 0.7 0.82 (0.29, 2.28) 7 (50) 0.54 1.38 (0.47, 3.98) 2 (28.57) 0.46 0.54 (0.10, 2.83)
≥ 5 65 (9.82) 4 (25) 0.03 3.19 (1.00, 10.21) 2 (14.29) 0.57 1.54 (0.33, 7.07) 2 (28.57) 0.09 3.75 (0.71, 19.77)
Contraceptive methods
Hormonal 102 (15.41) 1 (6.25) 0.3 0.36 (0.04, 2.75) 1 (7.14) 0.38 0.41 (0.05, 3.22) 1 (14.29) 0.93 0.91 (0.10, 7.67)
Condom 249 (37.61) 4 (25.00) 0.29 0.546 (0.17, 1.71) 7 (50) 0.33 1.67 (0.58, 4.84) 0 (0) 0.03
IUD 67 (10.12) 3 (18.75) 0.24 2.09 (0.58, 7.56) 1 (7.14) 0.7 0.67 (0.08, 5.26) 2 (28.57) 0.1 3.63 (0.69, 19.09)
Bilateral tubal occlusion 40 (6.04) 2 (12.50) 0.27 2.28 (0.50, 10.42) 2 (14.29) 0.19 2.67 (0.57, 12.38) 0 (0) 0.5
None 204 (30.82) 6 (37.50) 0.55 1.35 (0.48, 3.78) 3 (21.43) 0.44 0.60 (0.16, 2.19) 4 (57.14) 0.12 3.03 (0.67, 13.67)
      Alcohol use 145 (21.90) 4 (25) 0.54 1.19 (0.37, 3.75) 4 (28.57) 0.54 1.43 (0.44, 4.65) 1 (14.29) 0.62 0.59 (0.07, 4.95)
      Current smoker 200 (30.21) 5 (31.25) 0.29 1.05 (0.36, 3.06) 6 (42.86) 0.29 1.75 (0.60, 5.12) 2 (28.57) 0.924 0.92 (1.78, 4.89)
Biological factors 2 (28.57)
      Pregnant at sampling 287 (43.35) 7 (43.75) 0.25 1.01 (0.37, 2.76) 4 (28.57) 0.25 0.51 (0.16, 1.66) 6 (85.71) 4.28 0.51 (0.10, 2.69)
      Previous pregnancies 621 (93.81) 16 (100) 0.9 13 (92.86) 0.9 0.87 (0.11, 6.87) 2 (28.57) 0.38 0.40 (0.04, 3.40)
Complications of previous pregnancy 
Infections 386 (58.31) 8 (50) 0.31 0.70 (0.26, 1.91) 10 (71.43) 0.31 1.8 (0.56, 5.82) 0 (0) 0.1 0.28 (0.05, 1.46)
Bleeding 69 (10.42) 1 (6.25) 0.17 0.56 (0.07, 4.35) 3 (21.43) 0.17 2.4 (0.65, 8.84) 0 (0) 0.36
Risk of spontaneous abortion 116 (17.52) 0 (0) 0.74 1.58 (0.50, 5.01) 2 (14.29) 0.74 0.78 (0.17, 3.53) 0 (0) 0.22
Premature birth 50 (7.55) 0 (0) 0.28 0 (0.00) 0.28 0 (0) 0.44
Ectopic pregnancy 9 (1.36) 0 (0) 0.65 0 (0) 0.65 0 (0) 0.76
Previous abortions 163 (24.62) 2 (12.50) 0.99 3 (21.43) 0.99 2 (28.57) 0.99
Pelvic inflammatory disease 295 (44.56) 8 (50) 0.67 1.25 (0.46, 3.37) 7 (50) 0.67 1.25 (0.43, 3.60) 3 (42.86) 0.92 0.93 (0.20, 4.19)
Coinfections
HPV (PCR) 92 (13.90) 1 (6.25) 0.96 2 (14.3) 0.96 1.03 (0.22, 4.69) 3 (42.9) 0.02 4.77 (1.05, 21.66)
HIV (Serology) 45 (6.80) 2 (12.5) 0.26 0.40 (0.05, 3.11) 2 (14.3) 0.26 2.34 (0.50, 10.81) 1 (14.3) 0.42 2.31 (0.27, 19.65)
T. pallidum (Serology) 15 (2.27) 0 (0) 0.56 0 (0) 0.56 3 (42.9) 0 40.18 (8.09, 199.48)
T. pallidum (PCR) 7 (1.06) 1 (6.25) 0.02 7.11 (0.80, 62.78) 1 (7.1) 0.02 8.23 (0.92, 73.32) 0
0.71
HSV-2 (PCR) 12 (1.81) 2 (12.5) 0.13 9.08 (1.82, 43.35) 2 (7.1) 0.13 4.45 (0.53, 37.09) 0
M. genitalium (PCR) 16 (2.42) 0 3 (21.4) 0 13.32 (3.31, 53.46) 1 (14.3) 0.04 7.11 (0.80, 62.78)
T. vaginalis (PCR) 94 (14.20) 5 (31.25) 0.12 2.84 (0.96, 8.38) 0 (0) 0.12 4 (57.1) 0.001 8.37 (1.84, 38.01)
N. gonorrhoeae (PCR) 14 (2.11) 3 (18.75) 13.32 (3.31, 53.46) 1 (14.3) 0.02 8.23 (0.92, 73.32)
HSV-1(PCR) 56 (8.46) 4 (25) 0.006 3.8 (1.18, 12.22) 4 (28.6) 0.006 4.58 (1.39, 15.12) 2 (28.6) 0.06 4.45 (0.84, 23.49)
(continuation)
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 M. genitalium is detected more often in people with 
risk factors for the infection, reaching percentages from 
20 to 40% among sex workers.23 The prevalence of M. 
genitalium infections reported in the general population 
varies from 1 to 10% in most populations,24 but signifi-
cant differences are reported worldwide. A frequency of 
0.5% has been reported for Mexico.17 These differences 
underline the relevance of studing the frequency of this 
opportunistic pathogen in different populations.
 Two Mexican studies showed frequencies of 33.825 
and 18.4%17 for HPV. Both reports showed higher fre-
quencies than ours. A third Mexican report showed a 
frequency of 9.1%.26 All reports used different method-
ologies and studied different populations. These factors 
may explain the different frequencies observed.
 The genotype most frequently detected in our study 
was type 16, which is the most common genotype found 
in healthy women worldwide27 and the WHO reports 
that is one of the most frequent genotypes.
 In our study, the 18 genotype was detected in only 
one patient, representing the 1.1% of the HPV-positive 
population; the mean prevalence of the 18 genotype 
was previously reported for the Mexican population.17 
This data is relevant because genotype 18 is associated 
with more aggressive behavior and is detected mainly 
in high-grade lesions.28
 Our study showed the prevalence of HSV-1/HSV-2 
detected by PCR; the studies reported at present of the 
prevalence of these viruses are mainly by serological 
tests. The differences in methodologies make it difficult 
to make a comparison of frequencies of this virus. As 
expected, we detected lower frequencies than observed 
by serology. Contrary to expected it is interesting that 
there is a higher percentage of HSV-1 than HSV-2. Fur-
ther studies need to understand the basis of this switch.
 In this study, patients with five or more sexual 
partners were more likely to be HIV or HPV infected. 
Several studies have consistently shown that the risk 
of HPV and HIV infection increase with the number of 
sexual partners.29-31 Our results are in agreement with 
these studies.
 The differences between the frequencies reported 
of STIs among countries could represent genuine differ-
ences in patterns of sexual behavior and efforts to control 
these infections, but may also be the result of variations 
in study design, diagnostic methods, and participation 
rates. Reliable data on the frequency of these infections 
are scarce and often more about the age-specific region 
as well as its association with different risk factors; 
the diagnosis of STIs is not routine, so the prevalence 
of STIs is not known in depth in our population. This 
study will contribute to increase the knowledge about 
the frequency of STIs in Mexico.
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